[The prognostic value of lymphocyte transformation by phytohemagglutinin in children with acute lymphatic leukemia].
The response to phytohemagglutinin (PHA) of lymphocytes from 62 children with acute lymphoblastic leukemia (ALL) was tested before and during cytostatic therapy. Nineteen patients were tested as well for reactivity in autologous mixed lymphocyte-blast cell cultures. The prognostic value of the results obtained has been assessed. Children remained longer in their first complete remission 1) if the response to PHA before therapy was normal or only slightly diminished, or 2) if it returned to normal as soon as complete remission was attained, and 3) if periodic intensification therapy was followed by a rebound in spontaneous lymphocyte proliferation. The stimulatory response to PHA during maintenance therapy and the reactivity in mixed lymphocyte- blast cell cultures were not helpful prognostic criteria. In conclusion, determination of the PHA responsiveness at specific times, i.e. before therapy, after remission induction and after periodic intensification therapy, could help identify poor risk patients in ALL.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000276:immunology*; D008213:Lymphocyte Activation; D010835:Phytohemagglutinins; D011379:Prognosis; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents; D010835:Phytohemagglutinins
Die prognostische Bedeutung der Lymphozytentransformierbarkeit durch Phythämagglutinin bei Kindern mit akuter lymphatischer Leukämie.